Aardvark Therapeutics raises $85 million in Series C financing led by Decheng Capital to advance development of ARD-101 for the treatment of hyperphagia in patients with Prader-Willi Syndrome
Amount Raised
$85 Million
Round Type
Series C
San DiegoManufacturingBiotechnologyInvestors
Description
Aardvark Therapeutics, Inc. has announced an oversubscribed Series C financing of $85 million led by Decheng Capital, with participation from a syndicate of new and existing investors. The proceeds from the financing will be used to complete the clinical trials required for regulatory approval of Aardvark's lead asset, ARD-101, and to advance other pipeline programs.
Quick answer
Aardvark Therapeutics raised $85 Million in a Series C round, dated May 9, 2024. Investors: Foundation For Prader Willi Research, Vickers Venture Partners, The Prader Willi Syndrome Association – Usa, Silver Arc Private Capital, Cantor Fitzgerald & Co., LG Technology Ventures, Laurion Capital Management and Walleye Capital. Aardvark Therapeutics is based in San Diego, California, United States.
- How much did Aardvark Therapeutics raise?
- Aardvark Therapeutics raised $85 Million in a Series C round on May 9, 2024.
- Who invested in Aardvark Therapeutics?
- Foundation For Prader Willi Research, Vickers Venture Partners, The Prader Willi Syndrome Association – Usa, Silver Arc Private Capital, Cantor Fitzgerald & Co., LG Technology Ventures, Laurion Capital Management and Walleye Capital are named as investors in this round.
- What does Aardvark Therapeutics do?
- Aardvark Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases, inflammation,..
- Where is Aardvark Therapeutics based and how big is it?
- Aardvark Therapeutics is based in San Diego, California, United States. Fundz records about 26 employees.
- Who are the decision-makers at Aardvark Therapeutics?
- Fundz holds 2 contacts at Aardvark Therapeutics, including the Director. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who to call at Aardvark Therapeutics, and when
A new round usually means Aardvark Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Aardvark Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Aardvark Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Aardvark Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Aardvark Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Aardvark Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.